Cargando…

Barriers to Oncology Biosimilars Uptake in the United States

Biosimilars are biological compounds that contain an active substance that is similar to the active substance in an already approved biologic. This commentary focuses on the barriers to the use of biosimilars in the United States.

Detalles Bibliográficos
Autores principales: Nabhan, Chadi, Valley, Amy, Feinberg, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291332/
https://www.ncbi.nlm.nih.gov/pubmed/30049886
http://dx.doi.org/10.1634/theoncologist.2018-0066
_version_ 1783380234514464768
author Nabhan, Chadi
Valley, Amy
Feinberg, Bruce A.
author_facet Nabhan, Chadi
Valley, Amy
Feinberg, Bruce A.
author_sort Nabhan, Chadi
collection PubMed
description Biosimilars are biological compounds that contain an active substance that is similar to the active substance in an already approved biologic. This commentary focuses on the barriers to the use of biosimilars in the United States.
format Online
Article
Text
id pubmed-6291332
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-62913322018-12-13 Barriers to Oncology Biosimilars Uptake in the United States Nabhan, Chadi Valley, Amy Feinberg, Bruce A. Oncologist Commentary Biosimilars are biological compounds that contain an active substance that is similar to the active substance in an already approved biologic. This commentary focuses on the barriers to the use of biosimilars in the United States. AlphaMed Press 2018-07-26 2018-11 /pmc/articles/PMC6291332/ /pubmed/30049886 http://dx.doi.org/10.1634/theoncologist.2018-0066 Text en © AlphaMed Press 2018
spellingShingle Commentary
Nabhan, Chadi
Valley, Amy
Feinberg, Bruce A.
Barriers to Oncology Biosimilars Uptake in the United States
title Barriers to Oncology Biosimilars Uptake in the United States
title_full Barriers to Oncology Biosimilars Uptake in the United States
title_fullStr Barriers to Oncology Biosimilars Uptake in the United States
title_full_unstemmed Barriers to Oncology Biosimilars Uptake in the United States
title_short Barriers to Oncology Biosimilars Uptake in the United States
title_sort barriers to oncology biosimilars uptake in the united states
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291332/
https://www.ncbi.nlm.nih.gov/pubmed/30049886
http://dx.doi.org/10.1634/theoncologist.2018-0066
work_keys_str_mv AT nabhanchadi barrierstooncologybiosimilarsuptakeintheunitedstates
AT valleyamy barrierstooncologybiosimilarsuptakeintheunitedstates
AT feinbergbrucea barrierstooncologybiosimilarsuptakeintheunitedstates